Q4β25 Psychedelic Lobbying Update
Each quarter, we provide a look at federal lobbying disclosures by psychedelic drug developers and nonprofits. Here, we share our analysis of the latest developments for our PΞ±+ subscribers.
External link. We are not responsible for the content.
Read more βMore From Psychedelic Alpha
PΞ±+ Psychedelic Bulletin #221: Helus Reports Murky Phase 2a Results; AtaiBeckley Says R-MDMA Met Safety Goal in SAD, Details Phase 3 Design for 5-MeO-DMT in TRD; Psilocybin for Smoking Cessation Study Published
Policy Round-Up: State Momentum, Congressional Signals, and Coloradoβs Data Build-Out β’ RAND Survey: Americans Divi...
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership fo...
PΞ±+ February 2026 Psychedelic Bill Roundup
A state-by-state and federal review of psychedelics-related bills introduced or advanced in February 2026, including ...
Latest News
A federal report encourages states to prepare for FDA approval of psychedelics; Could THC help with the psychedelic blinding problem?
Plus: Ketamine seized at the UK border hits record high; an Arizona ibogaine trial; Study reveals cell signaling that...
7 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. An independent media platform covering drugs, altered states & the culture surroundi...
Is βGas Station Mollyβ the Next Big Grey Market Drug?
It feels like MDMA, skips the comedown, and it's already on head shop shelves. But is it legal? [...] Read More... Th...
Scent, Ritual, and Altered States
Kamila Aubre explores scent and the psychedelic experience
Inside the First Ayahuasca Forum Hosted by Indigenous Peoples
100 Indigenous leaders will gather at the World Ayahuasca Forum to set the terms for ayahuasca's future. [...] Read M...
Can Psilocybin Protect Skin Cells From Premature Aging?
PLUS Carlos Castaneda, foraging for psilocybin mushrooms, and Resilient Pharmaceuticals. [...] Read More... The post ...